v3.26.1
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)
Pre-funded warrants
Common Stock
Pre-funded warrants
Additional Paid-In Capital
Preferred Stock
Series E-2 Preferred Stock
Preferred Stock
Common Stock
Series E-2 Preferred Stock
Common Stock
Additional Paid-In Capital
Series E-2 Preferred Stock
Additional Paid-In Capital
Accumulated Deficit
Series D preferred stock
Total
Balance beginning at Dec. 31, 2024       $ 520,778   $ 15   $ 261,116,351 $ (247,342,463)   $ 14,294,681
Balance beginning (in shares) at Dec. 31, 2024       35.6   1,535,996          
Balance beginning Series D preferred stock at Dec. 31, 2024                   $ 1,382,023  
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2024                   111.11  
Stock-based compensation               562,737     562,737
Net loss                 (6,604,029)   (6,604,029)
Balance ending Series D preferred stock at Mar. 31, 2025                   $ 1,382,023  
Balance ending Series D preferred stock (in shares) at Mar. 31, 2025                   111.11  
Balance ending at Mar. 31, 2025       $ 520,778   $ 15   261,679,088 (253,946,492)   8,253,389
Balance ending (in shares) at Mar. 31, 2025       35.6   1,535,996          
Balance beginning at Dec. 31, 2024       $ 520,778   $ 15   261,116,351 (247,342,463)   14,294,681
Balance beginning (in shares) at Dec. 31, 2024       35.6   1,535,996          
Balance beginning Series D preferred stock at Dec. 31, 2024                   $ 1,382,023  
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2024                   111.11  
Net loss                     (12,051,940)
Balance ending Series D preferred stock at Jun. 30, 2025                   $ 1,382,023  
Balance ending Series D preferred stock (in shares) at Jun. 30, 2025                   111.11  
Balance ending at Jun. 30, 2025       $ 520,778   $ 18   264,958,619 (259,394,403)   6,085,012
Balance ending (in shares) at Jun. 30, 2025       35.6   1,812,040          
Balance beginning at Mar. 31, 2025       $ 520,778   $ 15   261,679,088 (253,946,492)   8,253,389
Balance beginning (in shares) at Mar. 31, 2025       35.6   1,535,996          
Balance beginning Series D preferred stock at Mar. 31, 2025                   $ 1,382,023  
Balance beginning Series D preferred stock (in shares) at Mar. 31, 2025                   111.11  
Stock-based compensation               565,391     565,391
Exercise of warrants for preferred stock, net of issuance costs (Note 2)           $ 3   2,714,140     2,714,143
Exercise of warrants for preferred stock, net of issuance costs (Note 2) (in shares)           276,044          
Net loss                 (5,447,911)   (5,447,911)
Balance ending Series D preferred stock at Jun. 30, 2025                   $ 1,382,023  
Balance ending Series D preferred stock (in shares) at Jun. 30, 2025                   111.11  
Balance ending at Jun. 30, 2025       $ 520,778   $ 18   264,958,619 (259,394,403)   6,085,012
Balance ending (in shares) at Jun. 30, 2025       35.6   1,812,040          
Balance beginning at Dec. 31, 2025       $ 520,778   $ 42   277,149,844 (269,133,500)   8,537,164
Balance beginning (in shares) at Dec. 31, 2025       35.6   4,240,129          
Balance beginning Series D preferred stock at Dec. 31, 2025                   $ 1,382,023  
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2025                   111.11  
Stock-based compensation       $ 0   $ 0   451,869 0 $ 0 451,869
Net loss       0   0   0 (5,653,946) 0 (5,653,946)
Balance ending Series D preferred stock at Mar. 31, 2026                   $ 1,382,023  
Balance ending Series D preferred stock (in shares) at Mar. 31, 2026                   111.11  
Balance ending at Mar. 31, 2026       $ 520,778   $ 42   277,601,713 (274,787,446)   3,335,087
Balance ending (in shares) at Mar. 31, 2026       35.6   4,240,129          
Balance beginning at Dec. 31, 2025       $ 520,778   $ 42   277,149,844 (269,133,500)   8,537,164
Balance beginning (in shares) at Dec. 31, 2025       35.6   4,240,129          
Balance beginning Series D preferred stock at Dec. 31, 2025                   $ 1,382,023  
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2025                   111.11  
Net loss                     (12,584,598)
Balance ending at Jun. 30, 2026           $ 83   311,589,849 (281,718,099)   29,871,833
Balance ending (in shares) at Jun. 30, 2026           8,252,108          
Balance beginning at Mar. 31, 2026       $ 520,778   $ 42   277,601,713 (274,787,446)   3,335,087
Balance beginning (in shares) at Mar. 31, 2026       35.6   4,240,129          
Balance beginning Series D preferred stock at Mar. 31, 2026                   $ 1,382,023  
Balance beginning Series D preferred stock (in shares) at Mar. 31, 2026                   111.11  
Stock-based compensation               428,306     428,306
Issuance of common stock and pre-funded warrants, net of issuance costs           $ 38   31,657,032     31,657,070
Issuance of common stock and pre-funded warrants, net of issuance costs (in shares)           3,734,940          
Conversion of preferred stock into common stock $ 3 $ (3) $ (520,778)       $ 520,778 1,382,023   $ (1,382,023) 1,382,023
Conversion of preferred stock into common stock (in shares) 260,296   (35.6)   13,040 3,703       (111.11)  
Net loss                 (6,930,653)   (6,930,653)
Balance ending at Jun. 30, 2026           $ 83   $ 311,589,849 $ (281,718,099)   $ 29,871,833
Balance ending (in shares) at Jun. 30, 2026           8,252,108